Literature DB >> 17229866

Human herpesvirus 6 DNA levels in cerebrospinal fluid due to primary infection differ from those due to chromosomal viral integration and have implications for diagnosis of encephalitis.

Katherine N Ward1, Hoe Nam Leong, Anton D Thiruchelvam, Claire E Atkinson, Duncan A Clark.   

Abstract

The prevalence and concentration of human herpesvirus 6 (HHV-6) DNA in the cerebrospinal fluid (CSF) of the immunocompetent in primary infection was compared with that in viral chromosomal integration. Samples from 510 individuals with suspected encephalitis, 200 young children and 310 older children and/or adults, and 12 other patients were tested. HHV-6 DNA concentration (log(10) copies/ml) was measured in CSF, serum, and whole blood using PCR. Serum HHV-6 immunoglobulin G antibody was measured by indirect immunofluorescence. Primary infection was defined by antibody seroconversion and/or a low concentration of HHV-6 DNA (<3.0 log(10) copies/ml) in a seronegative serum. Chromosomal integration was defined by a high concentration of viral DNA in serum (>/=3.5 log(10) copies/ml) or whole blood (>/=6.0 log(10) copies/ml). The prevalences of CSF HHV-6 DNA in primary infection and chromosomal integration were 2.5% and 2.0%, respectively, in the young children (<2 years) and 0% and 1.3%, respectively, in the older children and/or adults. The mean concentration of CSF HHV-6 DNA in 9 children with primary infection (2.4 log(10) copies/ml) was significantly lower than that of 21 patients with viral chromosomal integration (4.0 log(10) copies/ml). Only HHV-6B DNA was found in primary infection, whereas in viral integration, 4 patients had HHV-6A and 17 patients HHV-6B. Apart from primary infection, chromosomal integration is the most likely cause of HHV-6 DNA in the CSF of the immunocompetent. Our results show that any diagnosis of HHV-6 encephalitis or other type of active central nervous system infection should not be made without first excluding chromosomal HHV-6 integration by measuring DNA load in CSF, serum, and/or whole blood.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17229866      PMCID: PMC1865851          DOI: 10.1128/JCM.02115-06

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  51 in total

1.  [Meningoencephalitis caused by HHV-6A in a previously healthy immunocompetent adult].

Authors:  Isabel Losada; Francisco Pozo; Antonio Tenorio; Diego Dámaso
Journal:  Med Clin (Barc)       Date:  2003-03-15       Impact factor: 1.725

2.  Use of immunoglobulin G antibody avidity for differentiation of primary human herpesvirus 6 and 7 infections.

Authors:  K N Ward; D J Turner; X C Parada; A D Thiruchelvam
Journal:  J Clin Microbiol       Date:  2001-03       Impact factor: 5.948

3.  In search of encephalitis etiologies: diagnostic challenges in the California Encephalitis Project, 1998-2000.

Authors:  Carol A Glaser; Sabrina Gilliam; David Schnurr; Bagher Forghani; Somayeh Honarmand; Nino Khetsuriani; Marc Fischer; Cynthia K Cossen; Larry J Anderson
Journal:  Clin Infect Dis       Date:  2003-03-03       Impact factor: 9.079

4.  Meningoencephalitis in an adult with human herpesvirus-6 infection.

Authors:  T P Sloots; I M Mackay; P Carroll
Journal:  Med J Aust       Date:  1993 Dec 6-20       Impact factor: 7.738

5.  Reactivation of human herpesvirus 6 during pregnancy.

Authors:  H Dahl; G Fjaertoft; T Norsted; F Z Wang; M Mousavi-Jazi; A Linde
Journal:  J Infect Dis       Date:  1999-12       Impact factor: 5.226

6.  Case of fatal encephalitis by HHV-6 variant A.

Authors:  M Portolani; M Pecorari; M G Tamassia; W Gennari; F Beretti; G Guaraldi
Journal:  J Med Virol       Date:  2001-09       Impact factor: 2.327

7.  Fatal human herpesvirus 6-associated multifocal meningoencephalitis in an adult female patient.

Authors:  B Beović; N Pecaric-Meglic; J Marin; J Bedernjak; I Muzlovic; M Cizman
Journal:  Scand J Infect Dis       Date:  2001

8.  Evaluation of the specificity and sensitivity of indirect immunofluorescence tests for IgG to human herpesviruses-6 and -7.

Authors:  K N Ward; X Couto Parada; J Passas; A D Thiruchelvam
Journal:  J Virol Methods       Date:  2002-10       Impact factor: 2.014

9.  Human herpesvirus 6 (HHV-6) is transmitted from parent to child in an integrated form and characterization of cases with chromosomally integrated HHV-6 DNA.

Authors:  Keiko Tanaka-Taya; Junji Sashihara; Hiroki Kurahashi; Kiyoko Amo; Hiromi Miyagawa; Kazuhiro Kondo; Shintaro Okada; Koichi Yamanishi
Journal:  J Med Virol       Date:  2004-07       Impact factor: 2.327

10.  Successful treatment of human herpesvirus 6 encephalomyelitis in immunocompetent patient.

Authors:  Eric Denes; Laurent Magy; Karine Pradeau; Sophie Alain; Pierre Weinbreck; Sylvie Ranger-Rogez
Journal:  Emerg Infect Dis       Date:  2004-04       Impact factor: 6.883

View more
  43 in total

Review 1.  Heterogeneous pathways of maternal-fetal transmission of human viruses (review).

Authors:  A Saleh Younes; Márta Csire; Beatrix Kapusinszky; Katalin Szomor; Mária Takács; György Berencsi
Journal:  Pathol Oncol Res       Date:  2009-09       Impact factor: 3.201

2.  Chromosomal integration of the HHV-6 genome as a possible cause of persistent HHV-6 detection in a patient with langerhans cell histiocytosis.

Authors:  Volker Strenger; Christian Urban
Journal:  Pathol Oncol Res       Date:  2010-03       Impact factor: 3.201

3.  Diagnostic strategy used to establish etiologies of encephalitis in a prospective cohort of patients in England.

Authors:  H E Ambrose; J Granerod; J P Clewley; N W S Davies; G Keir; R Cunningham; M Zuckerman; K J Mutton; K N Ward; S Ijaz; N S Crowcroft; D W G Brown
Journal:  J Clin Microbiol       Date:  2011-08-24       Impact factor: 5.948

4.  Prevalence of chromosomally integrated human herpesvirus 6 in patients with human herpesvirus 6-central nervous system dysfunction.

Authors:  Joshua A Hill; Ruth Hall Sedlak; Danielle M Zerr; Meei-Li Huang; Cecilia Yeung; David Myerson; Keith R Jerome; Michael J Boeckh
Journal:  Biol Blood Marrow Transplant       Date:  2014-09-22       Impact factor: 5.742

Review 5.  Autoimmune encephalitis as differential diagnosis of infectious encephalitis.

Authors:  Thaís Armangue; Frank Leypoldt; Josep Dalmau
Journal:  Curr Opin Neurol       Date:  2014-06       Impact factor: 5.710

6.  Herpesvirus infections of the central nervous system in immunocompromised patients.

Authors:  Uta Meyding-Lamadé; Cornelia Strank
Journal:  Ther Adv Neurol Disord       Date:  2012-09       Impact factor: 6.570

Review 7.  Laboratory and clinical aspects of human herpesvirus 6 infections.

Authors:  Henri Agut; Pascale Bonnafous; Agnès Gautheret-Dejean
Journal:  Clin Microbiol Rev       Date:  2015-04       Impact factor: 26.132

8.  Human herpesvirus 6 meningoradiculitis treated with intravenous immunoglobulin and valganciclovir.

Authors:  Chafic Karam; Manuel Revuelta; Daniel Macgowan
Journal:  J Neurovirol       Date:  2008-09-23       Impact factor: 2.643

Review 9.  Acute viral infections of the central nervous system in immunocompetent adults: diagnosis and management.

Authors:  Marie Studahl; Lars Lindquist; Britt-Marie Eriksson; Göran Günther; Malin Bengner; Elisabeth Franzen-Röhl; Jan Fohlman; Tomas Bergström; Elisabeth Aurelius
Journal:  Drugs       Date:  2013-02       Impact factor: 9.546

10.  Case definitions, diagnostic algorithms, and priorities in encephalitis: consensus statement of the international encephalitis consortium.

Authors:  A Venkatesan; A R Tunkel; K C Bloch; A S Lauring; J Sejvar; A Bitnun; J-P Stahl; A Mailles; M Drebot; C E Rupprecht; J Yoder; J R Cope; M R Wilson; R J Whitley; J Sullivan; J Granerod; C Jones; K Eastwood; K N Ward; D N Durrheim; M V Solbrig; L Guo-Dong; C A Glaser
Journal:  Clin Infect Dis       Date:  2013-07-15       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.